Business Description
Legend Biotech Corp
NAICS : 541714
SIC : 2834
ISIN : US52490G1022
Share Class Description:
LEGN: ADRDescription
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.81 | |||||
| Equity-to-Asset | 0.65 | |||||
| Debt-to-Equity | 0.29 | |||||
| Debt-to-EBITDA | -1.4 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 6.23 | |||||
| Beneish M-Score | -1.91 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 36.6 | |||||
| 3-Year EBITDA Growth Rate | -2.5 | |||||
| 3-Year EPS without NRI Growth Rate | -2.8 | |||||
| 3-Year FCF Growth Rate | -3.3 | |||||
| 3-Year Book Growth Rate | 15.2 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 78.61 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.19 | |||||
| 9-Day RSI | 27.63 | |||||
| 14-Day RSI | 32.23 | |||||
| 6-1 Month Momentum % | 15.63 | |||||
| 12-1 Month Momentum % | -22.4 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.84 | |||||
| Quick Ratio | 4.78 | |||||
| Cash Ratio | 4.39 | |||||
| Days Inventory | 37.75 | |||||
| Days Sales Outstanding | 21.05 | |||||
| Days Payable | 55.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11 | |||||
| Shareholder Yield % | -0.34 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 60.28 | |||||
| Operating Margin % | -81.36 | |||||
| Net Margin % | -62.5 | |||||
| FCF Margin % | -36.1 | |||||
| ROE % | -22.54 | |||||
| ROA % | -15.5 | |||||
| ROIC % | -94.78 | |||||
| 3-Year ROIIC % | -87.3 | |||||
| ROC (Joel Greenblatt) % | -136.26 | |||||
| ROCE % | -16.43 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 16.21 | |||||
| PB Ratio | 6.39 | |||||
| Price-to-Tangible-Book | 7.32 | |||||
| EV-to-EBIT | -24.41 | |||||
| EV-to-Forward-EBIT | 71.05 | |||||
| EV-to-EBITDA | -26.58 | |||||
| EV-to-Forward-EBITDA | 63.76 | |||||
| EV-to-Revenue | 14.16 | |||||
| EV-to-Forward-Revenue | 5.53 | |||||
| EV-to-FCF | -39.05 | |||||
| Price-to-Net-Current-Asset-Value | 9.39 | |||||
| Price-to-Net-Cash | 11.31 | |||||
| Earnings Yield (Greenblatt) % | -4.1 | |||||
| FCF Yield % | -2.21 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:LEGN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Legend Biotech Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 455.991 | ||
| EPS (TTM) ($) | -1.54 | ||
| Beta | 0.13 | ||
| Volatility % | 50.35 | ||
| 14-Day RSI | 32.23 | ||
| 14-Day ATR ($) | 2.308467 | ||
| 20-Day SMA ($) | 43.55775 | ||
| 12-1 Month Momentum % | -22.4 | ||
| 52-Week Range ($) | 38.6 - 70.13 | ||
| Shares Outstanding (Mil) | 184.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Legend Biotech Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Legend Biotech Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Legend Biotech Corp Frequently Asked Questions
What is Legend Biotech Corp(LEGN)'s stock price today?
The current price of LEGN is $40.43. The 52 week high of LEGN is $70.13 and 52 week low is $38.60.
When is next earnings date of Legend Biotech Corp(LEGN)?
The next earnings date of Legend Biotech Corp(LEGN) is 2024-11-12.
Does Legend Biotech Corp(LEGN) pay dividends? If so, how much?
Legend Biotech Corp(LEGN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers